Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $12.3 million.

  • Molecular Partners Ag's Total Current Liabilities rose 21.87% to $14,678 in Q3 2025 from the same period last year, while for Sep 2025 it was $14,678, marking a year-over-year increase of 21.87%. This contributed to the annual value of $12.3 million for FY2024, which is 76275.45% up from last year.
  • Per Molecular Partners Ag's latest filing, its Total Current Liabilities stood at $12.3 million for FY2024, which was up 76,275.45% from $16,051 recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Total Current Liabilities ranged from a high of $63.8 million in FY2020 and a low of $16,051 during FY2023.
  • Its 3-year average for Total Current Liabilities is $4.1 million, with a median of $17,907 in 2022.
  • Per our database at Business Quant, Molecular Partners Ag's Total Current Liabilities crashed by 99.92% in 2021 and then surged by 76,275.45% in 2024.
  • Molecular Partners Ag's Total Current Liabilities (Yearly) stood at $63.8 million in 2020, then tumbled by 99.92% to $50,825 in 2021, then tumbled by 64.77% to $17,907 in 2022, then dropped by 10.36% to $16,051 in 2023, then skyrocketed by 76,275.45% to $12.3 million in 2024.